Get started
Author

Kavita Natrajan

Interim analysis of safety and efficacy of ruxolitinib in patients with myelofibrosis and low platelet counts
2013 · Moshe Talpaz, Ronald Paquette, et al. · Journal of Hematology & Oncology · 95
PDF
FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma
2024 · Kavita Natrajan, Megha Kaushal, et al. · Clinical Cancer Research · 60
PDF
Are There True Non-Responders to Hydroxyurea in Sickle Cell Disease? a Multiparameter Analysis
2014 · Arati Rani Chand, Hongyan Xu, et al. · Blood · 22
Pomalidomide In Sickle Cell Disease: Phase I Study Of a Novel Anti-Switching Agent
2013 · Abdullah Kutlar, Paul S. Swerdlow, et al. · Blood · 15
Efficacy, Hematologic Effects, and Dose of Ruxolitinib in Myelofibrosis Patients with Low Starting Platelet Counts (50–100 × 109/L): A Comparison to Patients with Normal or High Starting Platelet Counts
2012 · Moshe Talpaz, Ronald Paquette, et al. · Blood · 14
Characteristics and Potential Biomarkers for Chronic Pain in Patients with Sickle Cell Disease
2015 · Nina Kuei, Niren Patel, et al. · Blood · 12
Long Term Outcome of Patients Enrolled Into STOP and STOP II Trials: A Single Center Experience
2012 · Gloria Sayer, Latanya Bowman, et al. · Blood · 7
A successful model to decrease early deaths in acute promyelocytic leukemia (APL) through the use of a simplified algorithm and expert support.
2014 · Anand P. Jillella, Ravindra B. Kolhe, et al. · Journal of Clinical Oncology · 4
Genetic Association Studies of Pain Phenotypes in Adult SCD Patients
2014 · Abdullah Kutlar, Leigh G Wells, et al. · Blood · 2
Plasma Biomarkers of Iron Regulation, Overload, and Inflammation in Sickle Cell Disease
2014 · Abhishek Mangaonkar, Niren Patel, et al. · Blood · 2
A Successful Model To Decrease Early and Preventable Deaths In Acute Promyelocytic Leukemia (APL) Through The Use Of a Simplified Algorithm and Expert Support In Experienced As Well As Smaller Leukemia Treatment Centers In The US
2013 · Anand P. Jillella, Ravindra B. Kolhe, et al. · Blood · 1
A simple but effective model to decrease early deaths in acute promyelocytic leukemia (APL).
2012 · Anand P. Jillella, Ibrahim Sadek, et al. · Journal of Clinical Oncology · 1
Inflammatory Pseudo-tumor of Ovary - A Case Report
2012 · Sunanda Bharatnur, Vani Ramkumar, et al. · The Internet Journal of Gynecology and Obstetrics · 1
Bilateral nonpitting edema and xerotic skin.
2018 · Kiran Joglekar, Christopher Jackson, et al. · PubMed
Detection of Pulmonary Platelet Thrombi in Acute Chest Syndrome in Sickle Cell Disease: Novel Findings in an Autopsy Case Series
2014 · Ciprian Anea, Amidat Adeyemi, et al. · Blood
Definition epidemiology natural history and clinical phases
2014 · Vamsi Kota, Kavita Natrajan
Pivotal Role Of Heat Shock Proteins In Monocyte and Endothelial Cell Pathology In Sickle Cell Disease
2013 · Nagavedi S. Umapathy, Kavita Natrajan, et al. · Blood
Retrospective Analysis of Core Decompression in Avascular Necrosis of the Femoral Head in Patients with Sickle Cell Disease.
2012 · Austin Cail, Kavita Natrajan, et al. · Blood
miRNA expression profiling of CD20+ plasma cell myeloma (PCM): Upregulation of miR-155 shedding new insight into disease biology and clinicopathologic behavior.
2012 · Ravindra Kolhe, Anand P. Jillella, et al. · Journal of Clinical Oncology
Allogeneic Transplantation Following Reduced Intensity Conditioning with Fludarabine and Melphalan In Patients with Advanced Myelofibrosis Is Associated with Unacceptable Rates of Acute Graft-Vs-Host Disease and Non-Relapse Mortality.
2010 · Samith Thomas Kochuparambil, Kavita Natrajan, et al. · Blood
Works count: 21
Citation count: 236
H-index: 7
I10-index: 6
Year
Topic
Type